NEW YORK, Sept 20 Zars Pharma Inc, a Salt Lake
City pharmaceutical company, has postponed its initial public
offering to next week, an underwriter said on Thursday.
The 5-million share offering was initially expected to
price on Wednesday, and then on Thursday.
The company, in an earlier filing with the U.S. Securities
and Exchange Commission, said it expected the share offering to
sell for between $14 and $16 per share.
Underwriters, led by Cowen & Co and CIBC World Markets,
have an option to purchase an additional 750,000 shares to
The company has been approved to list its stock on Nasdaq
under the symbol "ZARS" ZARS.O.
(Reporting by Lilla Zuill)